[Arsenic trioxide induced leukemic cell apoptosis relative to NF-kappaB activation]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Oct;13(5):764-8.
[Article in Chinese]

Abstract

To investigate the relationship of As(2)O(3)-induced leukemic cell apoptosis with NF-kappaB activation and expression of VEGF, MMP9, apoptosis of K562-n cells induced by As(2)O(3) was analyzed by Annexin V, the dynamic changes of NF-kappaB, MMP9 and VEGF expressions were detected by immunohistochemistry. The results showed that activity of NF-kappaB could be increased, accompanied by higher level of expression of MMP9 and VEGF when apoptosis of K562-n cells was induced by As(2)O(3). Dexamethasome not only increased significantly the apoptotic rate, but also suppressed the activation of NF-kappaB of K562-n cells induced by As(2)O(3). Furthermore, there was a positive correlation between the expression of MMP9, VEGF and the activity of NF-kappaB. It is concluded that As(2)O(3) can induce apoptosis, in the meanwhile, activate NF-kappaB and up-regulate expression of MMP9 and VEGF in K562-n cell line. The mechanism of apoptosis of K562-n cells enhanced by dexamethasome may be related to suppression of the activation of NF-kappaB and expression of MMP9 and VEGF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Arsenic Trioxide
  • Arsenicals / pharmacology*
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • K562 Cells
  • Matrix Metalloproteinase 9 / metabolism
  • NF-kappa B / metabolism*
  • Oxides / pharmacology*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Antineoplastic Agents
  • Arsenicals
  • NF-kappa B
  • Oxides
  • Vascular Endothelial Growth Factor A
  • Matrix Metalloproteinase 9
  • Arsenic Trioxide